Caricamento...
Oncolytic Virotherapy for the Treatment of Malignant Glioma
Malignant glioma is the most common primary brain tumor and carries a grim prognosis, with a median survival of just over 14 months. Given the poor outcomes with standard-of-care treatments, novel treatment strategies are needed. The concept of virotherapy for the treatment of malignant tumors dates...
Salvato in:
| Pubblicato in: | Neurotherapeutics |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5398989/ https://ncbi.nlm.nih.gov/pubmed/28265902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0516-0 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|